| Product Code: ETC6746707 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Lung Transplant Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Lung Transplant Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Lung Transplant Therapeutics Market - Industry Life Cycle |
3.4 China Lung Transplant Therapeutics Market - Porter's Five Forces |
3.5 China Lung Transplant Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Lung Transplant Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 China Lung Transplant Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 China Lung Transplant Therapeutics Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 China Lung Transplant Therapeutics Market Revenues & Volume Share, By Patient Demographics, 2021 & 2031F |
4 China Lung Transplant Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung diseases and respiratory conditions in China |
4.2.2 Technological advancements in lung transplant procedures and therapeutics |
4.2.3 Rising awareness and acceptance of lung transplant therapies in China |
4.3 Market Restraints |
4.3.1 High cost associated with lung transplant procedures and therapeutics |
4.3.2 Limited availability of donor lungs for transplant surgeries in China |
4.3.3 Stringent regulatory requirements and ethical considerations surrounding lung transplants |
5 China Lung Transplant Therapeutics Market Trends |
6 China Lung Transplant Therapeutics Market, By Types |
6.1 China Lung Transplant Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Lung Transplant Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Lung Transplant Therapeutics Market Revenues & Volume, By Immunosuppressant Drugs, 2021- 2031F |
6.1.4 China Lung Transplant Therapeutics Market Revenues & Volume, By Organ Preservation Products, 2021- 2031F |
6.1.5 China Lung Transplant Therapeutics Market Revenues & Volume, By Tissue Products, 2021- 2031F |
6.2 China Lung Transplant Therapeutics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Lung Transplant Therapeutics Market Revenues & Volume, By Chronic Obstructive Pulmonary Diseases (COPD), 2021- 2031F |
6.2.3 China Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Fibrosis, 2021- 2031F |
6.2.4 China Lung Transplant Therapeutics Market Revenues & Volume, By Septic Lung Disease, 2021- 2031F |
6.2.5 China Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 China Lung Transplant Therapeutics Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 China Lung Transplant Therapeutics Market Revenues & Volume, By Interstitial Pulmonary Fibrosis, 2021- 2031F |
6.2.8 China Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.9 China Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.3 China Lung Transplant Therapeutics Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 China Lung Transplant Therapeutics Market Revenues & Volume, By Cadaveric Lung Transplantation, 2021- 2031F |
6.3.3 China Lung Transplant Therapeutics Market Revenues & Volume, By Living Lung Transplantation, 2021- 2031F |
6.4 China Lung Transplant Therapeutics Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 China Lung Transplant Therapeutics Market Revenues & Volume, By Single-Lung Transplantation, 2021- 2031F |
6.4.3 China Lung Transplant Therapeutics Market Revenues & Volume, By Bilateral-Lung Transplantation, 2021- 2031F |
6.4.4 China Lung Transplant Therapeutics Market Revenues & Volume, By Heart-Lung Transplantation, 2021- 2031F |
6.4.5 China Lung Transplant Therapeutics Market Revenues & Volume, By Double Lung Transplantation, 2021- 2031F |
6.5 China Lung Transplant Therapeutics Market, By Patient Demographics |
6.5.1 Overview and Analysis |
6.5.2 China Lung Transplant Therapeutics Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 China Lung Transplant Therapeutics Market Revenues & Volume, By Adult, 2021- 2031F |
6.5.4 China Lung Transplant Therapeutics Market Revenues & Volume, By Paediatric, 2021- 2031F |
7 China Lung Transplant Therapeutics Market Import-Export Trade Statistics |
7.1 China Lung Transplant Therapeutics Market Export to Major Countries |
7.2 China Lung Transplant Therapeutics Market Imports from Major Countries |
8 China Lung Transplant Therapeutics Market Key Performance Indicators |
8.1 Average waiting time for lung transplant surgeries |
8.2 Success rate of lung transplant procedures in China |
8.3 Number of research and development initiatives focused on improving lung transplant outcomes |
9 China Lung Transplant Therapeutics Market - Opportunity Assessment |
9.1 China Lung Transplant Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Lung Transplant Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 China Lung Transplant Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 China Lung Transplant Therapeutics Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 China Lung Transplant Therapeutics Market Opportunity Assessment, By Patient Demographics, 2021 & 2031F |
10 China Lung Transplant Therapeutics Market - Competitive Landscape |
10.1 China Lung Transplant Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Lung Transplant Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here